News

Aprea Therapeutics Showcases Innovations at Upcoming Summit

Aprea Therapeutics Showcases Innovations at Upcoming Summit

Aprea Therapeutics Showcases Innovations at Upcoming Summit

Aprea Therapeutics, Inc. (NASDAQ: APRE) is making headlines as it prepares for two exciting presentations at the Maxim Healthcare Virtual Summit. This participation reflects Aprea's commitment to advancing precision oncology, a field that is rapidly evolving with the promise of targeted treatments.

Summit Presentation Highlights

Dr. Oren Gilad, the President and CEO of Aprea, will represent the company at the virtual summit, sharing insights and progress on their innovative approaches to cancer treatment.

Panel Discussion on Precision Oncology

One of the key sessions will focus on the "Precision and Immune Oncology Panel," scheduled for Wednesday from 2:00 to 3:00 PM ET. This session aims to delve into how precision medicine is reshaping cancer therapies, which is a core pillar of Aprea's strategic endeavors.

Engaging Fireside Chat

The second presentation by Dr. Gilad will be a fireside chat on Thursday from 3:30 to 4:00 PM ET. This informal discussion will allow for a deeper engagement on the innovative strategies Aprea is implementing, highlighting their dedication to developing cutting-edge solutions in oncology.

Understanding Aprea's Innovative Approach

Aprea Therapeutics focuses on precision oncology through synthetic lethality, a promising area that seeks to identify and exploit cancer cell vulnerabilities while sparing healthy tissues. The company's lead program, ATRN-119, is an investigative small-molecule ATR inhibitor. This therapy is designed for patients with specific solid tumors, and it exemplifies Aprea's commitment to personalized treatment.

Recent Developments

In addition to ATRN-119, Aprea has recently initiated clinical trials for APR-1051, an oral WEE1 inhibitor. These advancements underline Aprea's proactive stance in the oncology landscape and their objective to bring innovative therapies to patients in need.

Engaging with Aprea Therapeutics

Aprea Therapeutics encourages interested parties to engage further by visiting their investor relations website. This platform provides valuable information about their ongoing research, clinical trials, and overall mission to revolutionize cancer treatment.

Investor and Media Contacts

For additional inquiries, Mike Moyer from LifeSci Advisors can be reached for investor-related questions. Moreover, media inquiries can be directed to Ignacio Guerrero-Ros or David Schull at Russo Partners, who are available to shed more light on Aprea's initiatives and contributions to the field of oncology.

Frequently Asked Questions

What is Aprea Therapeutics known for?

Aprea Therapeutics is recognized for its focus on precision oncology through synthetic lethality, developing targeted therapies for cancer treatment.

Who will be presenting at the Maxim Healthcare Virtual Summit?

Dr. Oren Gilad, the President and CEO of Aprea Therapeutics, will be the primary presenter at the summit.

What are the key presentations at the summit?

The key presentations include a panel on "Precision and Immune Oncology" and a fireside chat discussing innovative oncology strategies.

What is ATRN-119?

ATRN-119 is Aprea's lead drug candidate, a small-molecule ATR inhibitor aimed at treating specific solid tumors.

How can I get in touch with Aprea Therapeutics?

For investor inquiries, Mike Moyer from LifeSci Advisors is available, and media inquiries should be directed to Russo Partners.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sacrifice Unending: 9/11's Lingering Health Toll

Updated Category News Views 1

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Continue Reading
WNET's 25th Anniversary 9/11 Tribute: Stories and Lessons

Updated Category News Views 2

Reflecting on a Dark Day with WNET's Programming Nothing quite hits you like the anniversary of a colossal tragedy. The memories of September 11, 2001, remain etched in the urban landscape of New York City, and this year marks 25 years since that heart-wrenching day. The WNET Group steps up to the plate with a comprehensive slate of programming aimed at honoring the...

Continue Reading
Midlife ADHD in Women: New Challenges and Solutions

Updated Category News Views 4

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 5

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 3

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 3

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 3

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
LeoLabs and SciTec Partner for $93.7M Space Force Deal

Updated Category News Views 2

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Continue Reading
South Florida Donor Network Honors 52 Heroic Donors

Updated Category News Views 4

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Continue Reading
EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Updated Category News Views 4

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Continue Reading

Top 5 Most Recently Viewed Articles

Pivot Bio Welcomes Melih Keyman to Board, Enhancing Expertise

Updated Category News Views 253

Pivot Bio Strengthens Leadership with New Board Member New director brings rich agriculture and fertilizer experience to the forefront of innovation Pivot Bio, recognized for its groundbreaking advancements in the agricultural technology sector, has appointed Melih Keyman to its Board of Directors. This strategic move is expected to bolster the company's growth and...

Continue Reading
Market Resilience Amid Global Uncertainties and Opportunities

Updated Category News Views 87

Market Resilience Amid Global Uncertainties Current market conditions suggest a renewed risk appetite among investors, with positive performance in equities driven by factors such as advancements in AI technology and robust corporate earnings. Despite geopolitical tensions, particularly concerning military actions, investors are finding reassurances that may support...

Continue Reading
PIQNIC Partners with NZME to Transform Accounts Payable Efficiency

Updated Category News Views 265

PIQNIC struck a significant deal back in 2024 with New Zealand Media and Entertainment (NZME) to overhaul their accounts payable (AP) processes. This partnership was like a shot of espresso for NZME’s AP headaches, managing thousands of invoices each month. Now, when you think about the avalanche of invoices coming in, it’s no wonder they turned to automation—manual...

Continue Reading
barq and Thunes Collaborate for Faster Cross-Border Payments

Updated Category News Views 339

barq and Thunes Unite for Enhanced Remittance Services Through a transformative partnership, barq and Thunes are set to revolutionize the remittance landscape in Saudi Arabia. With the integration of Thunes' robust Direct Global Network, barq is positioned to provide seamless money transfer services to numerous consumers across the Kingdom. This collaboration brings...

Continue Reading
Unlock Your Potential with INSEAD's New GEMBA Flex Program

Updated Category News Views 338

INSEAD Unveils the Global Executive MBA Flex Programme INSEAD, recognized as The Business School for the World, is excited to introduce the Global Executive MBA Flex (GEMBA Flex) programme. This new offering expands INSEAD's acclaimed GEMBA portfolio, catering to the changing needs of senior executives aiming for tailored professional advancement. Designed for Today's...

Continue Reading